Krintafel™ and the nigerian niger-delta region: The unheard story of the purported wonder drug
BACKGROUND: The July 2018 declaration of discovery of Krintafel™ , the first single-dose anti-malarial agent to prevent P. Vivax relapse, was clearly a significant step in pharmaceutical efforts geared towards malaria eradication. How much of the medical dialogue contained in that declaration trickl...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | Nigerian Journal of Medicine |
| Subjects: | |
| Online Access: | http://www.njmonline.org/article.asp?issn=1115-2613;year=2019;volume=28;issue=2;spage=152;epage=155;aulast=Taniyohwo;type=0 |